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he GTPase Rab13 regulates the assembly of func-
tional epithelial tight junctions (TJs) through a yet
unknown mechanism. Here, we show that expression
of the GTP-bound form of Rab13 inhibits PKA-dependent
phosphorylation and TJ recruitment of the vasodilator-
stimulated phosphoprotein, an actin remodelling protein.
We demonstrate that Rab13GTP directly binds to PKA and
T
 
inhibits its activity. Interestingly, activation of PKA abro-
gates the inhibitory effect of Rab13 on the recruitment of
vasodilator-stimulated phosphoprotein, ZO-1, and claudin1
to cell–cell junctions. Rab13 is, therefore, the ﬁrst GTPase
that controls PKA activity and provides an unexpected link
between PKA signaling and the dynamics of TJ assembly.
 
Introduction
 
During epithelial morphogenesis, the development and orga-
nization of cell asymmetry require the assembly of functional
tight junctions (TJs). TJs serve as a barrier to the paracellular
diffusion and prevent the movement of lipids and membrane
proteins between apical and basolateral membranes (Tsukita
et al., 2001; Matter and Balda, 2003). They form a network
of transmembrane, scaffolding, and signaling molecules that
control cell–cell adhesion, cell polarity, proliferation, and
differentiation (Zahraoui et al., 2000). The TJ transmem-
brane proteins, claudins, are required for the establishment of
TJ gate function (Tsukita and Furuse, 1999). Scaffolding
proteins such as ZO-1, a PDZ-containing protein, connect
transmembrane proteins to the underlying actin cytoskeleton
and recruit cytosolic proteins, such as kinases, GTPases, and
transcription factors to TJs (Itoh et al., 1999; Wittchen et al.,
1999; Balda and Matter, 2000). The actin cytoskeleton con-
tributes substantially to maintain TJ integrity (Madara et al.,
1992). In CaCo-2 cells, disruption of actin filaments with
cytochalasin D decreases, and stabilization of F-actin increases
barrier function (Madara et al., 1986; Balda et al., 1993).
Recently, vasodilator-stimulated phosphoprotein (VASP), a
key actin remodelling protein, has been implicated in epithelial
TJ biogenesis (Lawrence et al., 2002). VASP was shown to be
a substrate for both PKA and PKG (Butt et al., 1994), and
phosphorylation of VASP abolishes its interaction with actin
and inhibits actin polymerization, assigning VASP a key role
in controlling actin dynamics (Harbeck et al., 2000). How-
ever, the regulatory pathways that link actin cytoskeleton
organization to the assembly of TJ still need to be elucidated.
Interestingly, activation of the small GTPases, Rho/Rac,
induces the reorganization of the perijunctional actin ring
and leads to increased paracellular permeability (Takaishi et
al., 1997; Benais-Pont et al., 2003).
Another family of small GTPases, Rab proteins, is also
involved in regulating TJ dynamics. Rab GTPases seem to
regulate specific membrane transport events including vesicle
formation, motility via kinesins or myosins, tethering, and
fusion (Pfeffer, 2001; Zerial and McBride, 2001). We have
shown previously that Rab13 is recruited from a cytoplasmic
pool to cell–cell contacts at an early stage during TJ assembly
(Zahraoui et al., 1994; Sheth et al., 2000). Expression of the
active (Rab13Q67L), but not the inactive (Rab13T22N)
mutant of Rab13 in epithelial MDCK cells delays the recruit-
ment of TJ proteins, claudin1 and ZO-1, and alters TJ
integrity. Interestingly, it does not impair the recruitment of
E-cadherin to the lateral membrane (Marzesco et al., 2002).
Nevertheless, how Rab13 interferes with TJ structure and
function is still unclear. In the present work, we show that the
active mutant Rab13Q67L inhibits PKA-mediated phosphor-
ylation of VASP and its recruitment to cell–cell junctions.
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Moreover, Rab13GTP binds to PKA and inhibits its activity.
Our data provide new insights into the molecular mechanisms
by which Rab13 regulates TJ assembly in epithelial cells.
 
Results and discussion
 
Rab13Q67L prevents the recruitment of VASP to TJs
 
The effect of GFP-Rab13Q67L on TJ protein recruitment
(Marzesco et al., 2002) suggests that Rab13 regulates some
aspects of actin cytoskeleton–TJ interactions. Because VASP
is involved in the establishment of TJ barrier (Lawrence et
al., 2002), we tested whether Rab13 mutants could affect
VASP localization during TJ assembly. We used the Ca
 
2
 
 
 
switch protocol, a model system to study TJ assembly. Cells
were plated in medium without Ca
 
2
 
 
 
 for 16 h to dissociate
cell–cell junctions, followed by the addition of Ca
 
2
 
 
 
 to trig-
ger synchronous junction assembly. The localization of
VASP was analyzed by immunofluorescence at 0, 2, and 4 h
after induction of cell–cell contacts. In control cells, as well
as in cells expressing GFP-Rab13T22N and Q67L mutants,
removal of Ca
 
2
 
 
 
 resulted in the dissociation of cell–cell junc-
tions and redistribution of VASP into the cytoplasm (Fig.
1). Restoration of physiological Ca
 
2
 
 
 
 concentrations in-
duced an increased plasma membrane labeling of VASP at
sites of cell–cell contacts in cells expressing GFP or GFP-
Rab13T22N. In contrast, in GFP-Rab13Q67L cells, within
4 h after the addition of Ca
 
2
 
 
 
, VASP was not detected at
cell–cell contacts and was still cytoplasmic (Fig. 1). This in-
dicated that Rab13Q67L inhibits the recruitment of VASP
to sites of cell–cell contacts during junction assembly.
 
Rab13 controls PKA-dependent phosphorylation of VASP 
and its subsequent recruitment to cell–cell junctions
 
Because phosphorylated VASP (P-VASP) accumulates at
cell–cell junctions under conditions that enhance barrier re-
covery, it was proposed that P-VASP is a component of TJs
(Lawrence et al., 2002). VASP phosphorylation on residue
Ser157 results in a conformational change concomitant with
a shift in SDS-PAGE mobility from 46 to 50 kD (Butt et
al., 1994). Thus, we tested whether Rab13Q67L could
interfere with VASP phosphorylation. Using a monoclo-
nal anti-VASP antibody that recognizes nonphosphory-
lated as well as P-VASP, we found that in MDCK cells and
cells expressing GFP or GFP-Rab13T22N, both forms of
VASP were detected. In contrast, in cells expressing GFP-
Rab13Q67L, only the 46-kD band corresponding to the
nonphosphorylated form of VASP was detected (Fig. 2 A).
This indicates that GFP-Rab13Q67L inhibited phosphory-
lation of VASP at Ser157. To confirm these results, the same
cell lysates used in Fig. 2 A were blotted with an anti-VASP
antibody that specifically recognizes VASP phosphorylated
at Ser157 (P-VASP). This antibody detected the 50-kD
band corresponding to P-VASP in cells expressing GFP-
Rab13T22N and in control cells, whereas no P-VASP spe-
cific band was observed in GFP-Rab13Q67L cell lysate (Fig.
2 B). Thus, the expression of Rab13Q67L specifically inhib-
its the phosphorylation of VASP at Ser157 in MDCK cells.
VASP phosphorylation at Ser157 was observed upon
stimulation of PKA or PKG (Burkhardt et al., 2000). To de-
termine which kinase is responsible for the Rab13-depen-
dent phosphorylation of VASP, we examined the effect of
specific kinase inhibitors and activators on VASP phosphor-
ylation. As shown in Fig. 3 A, incubation with both PKG
and PKC inhibitors did not significantly reduce the phos-
phorylation of VASP in control cells or cells expressing
GFP-Rab13T22N. In contrast, incubation with the PKA in-
hibitor H89 decreased the amount of P-VASP in a dose-
dependent manner, indicating that the effect on VASP-
phosphorylation is specific. Moreover, treatment of cells
expressing Rab13Q67L with 8-Br-cGMP, an activator of
PKG, did not induce phosphorylation of VASP in those
cells. Conversely, activation of PKA by either 8-Br-cAMP
or Forskolin restored VASP phosphorylation in GFP-
Rab13Q67L cells as monitored by the presence of the 50-
kD band of VASP (Fig. 3 B). These data indicate that
Rab13-dependent phosphorylation of VASP in MDCK cells
is mediated by PKA, but not PKC or PKG.
Figure 1. Rab13Q67L inhibits the recruitment of VASP to cell–cell 
junctions during TJ formation. MDCK cells expressing GFP, GFP-
Rab13T22N, or GFP-Rab13Q67L were incubated for 16 h without 
Ca
2 , then Ca
2  was added back for the time indicated and the cells 
stained with a monoclonal anti-VASP antibody. Within 2–4 h after 
the Ca
2  switch, VASP was detected at cell–cell junctions in cells 
expressing GFP and GFP-Rab13T22N (arrows), but not in those 
expressing GFP-Rab13Q67L. Bar, 10  m.
Figure 2. The activated form of Rab13 inhibits phosphorylation 
of VASP. (A) Lysates from MDCK or cells expressing GFP, GFP-
Rab13T22N, or GFP-Rab13Q67L were blotted with the monoclonal 
anti-VASP antibody recognizing both the phosphorylated (50 kD) 
and non phosphorylated (46 kD) form of VASP. In GFP-Rab13Q67L 
cells, the 50-kD band was not detected. (B) The same lysates as in A 
were blotted with a specific antibody recognizing VASP phosphory-
lated at Ser157 (P-VASP). Note that P-VASP was absent in cells 
expressing GFP-Rab13Q67L. Similar results were obtained from 
three independent GFP-Rab13T22N and GFP-Rab13Q67L mutants. 
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To investigate whether VASP phosphorylation is required
for its recruitment to cell–cell junctions, MDCK cells ex-
pressing GFP-Rab13Q67L or GFP-Rab13T22N were incu-
bated with Forskolin and H89, respectively, and P-VASP lo-
calization was examined by immunofluorescence using the
antibody recognizing P-VASP. In the absence of Forskolin,
no P-VASP could be detected at cell–cell junctions in cells
expressing GFP-Rab13Q67L (Fig. 3 C). However, activation
of PKA by Forskolin restored the recruitment of P-VASP to
cell–cell junctions in those cells. In contrast, in cells express-
ing GFP-Rab13T22N, P-VASP was detected at cell–cell
junctions. Treatment of those cells with the specific PKA in-
hibitor H89 removed P-VASP from cell–cell junctions (Fig.
3 C). Overall, our results demonstrate that activation of
Rab13 inhibits PKA-mediated phosphorylation of VASP and
prevents its association with intercellular junctions.
 
Activation of PKA abolishes the inhibitory effect 
of Rab13Q67L on the recruitment of TJ proteins, 
ZO-1 and claudin1
 
To determine whether the effect of Rab13 on claudin1 and
ZO-1 recruitment could be mediated by PKA, we examined
the consequences of PKA activation on the recruitment of ZO-1
and claudin1 in cells expressing GFP-Rab13Q67L using the
Ca
 
2
 
 
 
 switch assay. In control cells as well as in cells express-
ing GFP-Rab13T22N or GFP-Rab13Q67L, removal of Ca
 
2
 
 
 
resulted in the dissociation of cell–cell junctions and re-
distribution of ZO-1 and claudin1 into the cytoplasm (Fig.
4). By 2 h after addition of Ca
 
2
 
 
 
, ZO-1 immunoreactivity
was already detected at cell–cell junctions in cells expressing
GFP and GFP-Rab13T22N. In contrast, expression of GFP-
Rab13Q67L delayed slightly the recruitment of ZO-1; ZO-1
labeling was discontinuous along the lateral membrane. By 4 h
after readdition of calcium, ZO-1 staining was detected at
the plasma membrane, but some ZO-1 immunoreactivity was
still observed in the cytoplasm in cells expressing GFP-
Rab13Q67L (Fig. 4 A). Similarly, plasma membrane recruit-
ment of claudin1 was delayed in cells expressing GFP-
Rab13Q67L. Within 6–12 h after readdition of calcium, most
of the claudin1 staining was still cytoplasmic in GFP-
Rab13Q67L cells, whereas claudin1 was detected at the plasma
membrane in cells expressing GFP or GFP-Rab13T22N (Fig.
4 B). Significantly, activation of PKA with Forskolin restored
the kinetics of both ZO-1 and claudin1 recruitment to the lat-
eral membrane in GFP-Rab13Q67L cells (Fig. 4). This indi-
cates that PKA activation abolished the inhibitory effect of
Rab13GTP on the recruitment of TJ proteins, leading to their
accumulation at cell–cell junctions. Our data establish that the
Rab13–PKA signaling complex plays a key role in TJ biogene-
sis. They further confirm that PKA-dependent phosphoryla-
tion is implicated in the dynamics of epithelial TJ.
 
Rab13GTP binds to the PKA catalytic subunit and 
inhibits its activity in vitro
 
Given that Rab13 interferes with PKA signaling in the regu-
lation of TJ assembly, we wondered whether and how
Rab13 interacts with PKA. Thus, we performed a GST pull-
down assay from MDCK cell lysates using GST-Rab13 fu-
sion proteins. GST alone or GST-Rab13 were immobilized
on glutathione beads, preloaded either with GDP or GTP
 
 
 
S
(a poorly hydrolysable GTP analogue), and incubated with
MDCK cell lysates. The proteins retained on the beads were
separated on SDS-PAGE and blotted with an antibody
against the 
 
 
 
 catalytic subunit of PKA. As shown in Fig. 5 A,
the 
 
 
 
 catalytic subunit of PKA, but not atypical PKC
 
 
 
(aPKC
 
 
 
), was preferentially recovered with GST-Rab13
Figure 3. Rab13 regulates PKA-mediated VASP phosphorylation, 
thereby controlling VASP recruitment to cell–cell junctions. 
(A) PKA inhibition decreases VASP phosphorylation. MDCK or 
cells expressing GFP or GFP-Rab13T22N were treated with inhibitors 
of PKG (KT5823), PKC (Rö-32-0432), or PKA (H89) and the lysates 
blotted for VASP. (B) Activation of PKA by Forskolin or cAMP, 
but not that of PKG by cGMP restores VASP phosphorylation in 
Rab13Q67L cells. Cells expressing GFP-Rab13Q67L were incubated 
with Forskolin (Fsk), 8-Br-cAMP or 8-Br-cGMP and VASP was 
detected by immunoblot. Nontreated cells were blotted as a control. 
(C) Cells expressing GFP-Rab13Q67L or GFP-Rab13T22N were 
treated with Forskolin (Fsk) or the PKA inhibitor (H89), respectively, 
and analyzed by immunofluorescence with the anti–P-VASP antibody. 
P-VASP was not detected at cell–cell junctions in Rab13Q67L cells, 
but relocated to TJ upon PKA activation. Inhibition of PKA removed 
P-VASP from cell–cell contacts in cells expressing Rab13T22N. 
P-VASP was found in cell–cell contacts where junctional complexes 
developed with neighboring cells (arrows), and absent from the edges 
of cells devoid of junctional complexes (arrowheads). Bar, 10  m. 
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loaded with GTP
 
 
 
S, whereas GST alone did not interact
with PKA or aPKC
 
 
 
. To verify whether the Rab13–PKA in-
teraction is direct, GST-Rab13 loaded with GDP, GTP
 
 
 
S,
or GST alone were incubated with a purified preparation of
PKA catalytic subunit. Blotting with the anti-PKA antibody
revealed that PKA preferentially bound to GST-Rab13-
GTP
 
 
 
S, but neither to GST alone, nor to GST-Rab6GTP
 
 
 
S
(Fig. 5 B), indicating that Rab13 interacts directly and spe-
cifically with the PKA catalytic subunit.
Because the GTP bound form of Rab13 inhibits PKA-
dependent VASP phosphorylation in vivo, we next determined
whether Rab13GTP interferes with PKA activity in vitro.
VASP was immunoprecipitated from cells expressing GFP-
Rab13Q67L and used as a physiologically relevant substrate
for PKA in a kinase assay. PKI, a potent peptide inhibitor of
PKA, was used as a positive control in these experiments. In-
cubation of VASP with the catalytic subunit of PKA in-
duced VASP phosphorylation in vitro, resulting in a shift in
SDS-PAGE mobility from 46 to 50 kD (Fig. 5 C). Similarly
to PKI, GST-Rab13-GTP
 
 
 
S caused a strong inhibition of
PKA activity, whereas GST alone had no effect. The results
in vitro are concordant with those in vivo and demonstrate
that Rab13 is able to inhibit PKA activity.
In this paper, we identified PKA as a new effector for the
small GTPase Rab13. Our data demonstrate that the GTP
bound form of Rab13 directly binds and negatively controls
PKA activity both in vitro and in vivo. This is the first dem-
onstration of a biochemical and functional link between a
small Rab GTPase and the PKA catalytic subunit.
Protein phosphorylation/dephosphorylation events are re-
quired for the regulation of TJ dynamics (Sakakibara et al.,
1997; Matter and Balda, 2003). In these processes, VASP may
play a key role due to its differential actin binding capacities
depending on its state of phosphorylation. Phosphorylation of
VASP by PKA reduces VASP–actin interactions and promotes
the association of P-VASP with cell–cell junctions. Interest-
ingly, VASP is required for the establishment of cell–cell con-
tacts (Vasioukhin et al., 2000). Although Rab13 does not af-
fect the recruitment of E-cadherin (Marzesco et al., 2002) and
 
 
 
-catenin to cell–cell junctions (Fig. S1, available at http://
Figure 4. PKA activation abolishes the 
inhibitory effect of Rab13Q67L on the 
recruitment of ZO-1 and claudin1. Cells 
expressing GFP, GFP-Rab13T22N, or 
GFP-Rab13Q67L were grown without 
Ca
2  for 16 h and subsequently incubated 
in normal medium for the time indicated 
in the absence or presence of Forskolin 
(Fsk). The localization of (A) ZO-1 and 
(B) claudin1 was analyzed by immuno-
fluorescence. In cells expressing 
Rab13Q67L, the recruitment of ZO-1 
and claudin1 to cell–cell junctions was 
delayed. Forskolin treatment restored 
ZO-1 and claudin1 recruitment in those 
cells. Bars, 10  m.
Figure 5. Rab13GTP interacts in vitro directly with PKA and 
inhibits its activity. (A) MDCK cell lysates were incubated with GST 
or GST-Rab13 fusion proteins preloaded with GDP or GTP S. The 
retained proteins were analyzed by SDS-PAGE and immunoblotted 
with antibodies against the   catalytic subunit of PKA or aPKC . 
Equal loading was confirmed by ponceau staining. (B) GST-Rab13 
or GST-Rab6 preloaded with GDP, GTP S, or GST was incubated 
with the purified catalytic subunit of PKA. Proteins bound to the 
beads were separated by SDS-PAGE and blotted with the anti-PKA 
antibody. 48% of the PKA was recovered with GST-Rab13-GTP S. 
(C) VASP immunoprecipitate from cells expressing GFP-Rab13Q67L 
was incubated in an in vitro kinase assay with the purified catalytic 
subunit of PKA in the presence of PKI (a peptide inhibitor of PKA), 
GST-Rab13-GTP S, or GST. Samples were subjected to SDS-PAGE 
and immunoblotted with the anti-VASP antibody recognizing both 
phosphorylated and non–P-VASP. 
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www.jcb.org/cgi/content/full/jcb.200312118/DC1), we can-
not rule out the possibility that Rab13 alters TJ assembly
through regulating the recruitment of other adherens junction
components. We suggest that Rab13GTP could locally in-
fluence actin rearrangement by controlling PKA-dependent
VASP phosphorylation and hence inhibit TJ integrity. Our
previous data suggested that Rab13, in its GTP-bound form,
interacts with an effector that inhibits the recruitment of
claudin1 and, to a lesser extent, that of ZO-1 to TJ. Con-
versely, the inactive form Rab13T22N, unable to bind the
effector, favors the establishment of TJ gate and fence func-
tions (Marzesco et al., 2002). The inhibitory effect of the
Rab13Q67L mutant on TJ assembly and function could thus
be explained by the inhibition of PKA activity. The Rab13–
PKA signaling complex may as well regulate vesicle docking
near cell–cell junctions. Indeed, PKA activity has been shown
to be required for membrane trafficking (Pimplikar and Si-
mons, 1994; Rodionov et al., 2003). Therefore, our observa-
tions allow us to postulate the existence of a new signaling cas-
cade at the TJ implicating Rab13–PKA in the dynamics of TJ
assembly. They also highlight novel insights into the role of
Rab proteins in membrane–cytoskeleton interactions.
 
Materials and methods
 
Antibodies
 
Anti-VASP mAb was purchased from BD Transduction Laboratories;
monoclonal anti-VASP antibody specific for VASP phosphorylated at
Ser157 was purchased from NanoTools; polyclonal anti–ZO-1 and anti–
claudin-1 antibodies were purchased from Zymed Laboratories; anti-PKA
 
 
 
 cat and anti-PKC
 
 
 
 pAbs were purchased from Santa Cruz Biotechnology,
Inc. Secondary antibodies coupled to Cy2 or Cy5 were purchased from
Jackson ImmunoResearch Laboratories.
 
Cell culture
 
MDCK cells (clone II) were cultured in DME supplemented with 10% FCS,
2 mM glutamine, 100 U/ml penicillin, and 10 mg/ml streptomycin. The
cells were incubated at 37
 
 
 
C under 10% CO
 
2
 
 atmosphere. MDCK cells sta-
bly expressing GFP, GFP-Rab13T22N, or GFP-Rab13Q67L were described
previously (Marzesco et al., 2002).
 
Incubation with kinase inhibitors/activators
 
500,000 cells were plated onto 3.5-cm diam culture plates overnight and
incubated as follows: 1 h at 37
 
 
 
C with 30 
 
 
 
M of PKA inhibitor H-89; 30
min with the PKC and PKG inhibitors Rö-32-0432 (10 
 
 
 
M) or KT5823 (5
 
 
 
M; Calbiochem); 30 min with 100 
 
 
 
M cAMP or cGMP; or 20 min with
10 
 
 
 
M Forskolin (Sigma-Aldrich). Cells were washed three times in PBS
and subjected to either immunofluorescence or immunoblotting proce-
dures. We confirmed that Rö-32-0432 is effective in inhibiting PKC activity
under these conditions.
 
Ca
 
2
 
 
 
 switch experiments
 
MDCK cells expressing GFP or GFP-Rab13T22N and GFP-Rab13Q67L
mutants were plated at a density of 10,000,000 cells/cm
 
2
 
, and incubated
for 16 h in S-MEM medium without Ca
 
2
 
 
 
. Cells were rinsed with normal
DME, incubated in DME for the indicated time and analyzed by immuno-
fluorescence. When the effect of PKA activation/inhibition was studied,
Forskolin and H89 were added to DME after the Ca
 
2
 
 
 
depletion.
 
Immunofluorescence microscopy
 
Immunofluorescence was performed as described previously (Marzesco et
al., 2002). The samples were analyzed with a fluorescence microscope
(Carl Zeiss MicroImaging Inc.) and further processed with Adobe Photo-
shop Software.
 
Immunoprecipitation and immunoblotting
 
500,000 MDCK or cells expressing GFP, GFP-Rab13T22N, or GFP-
Rab13T22N were grown on 3.5-cm diam culture plates for 16 h, washed
three times with ice-cold PBS, and extracted in 0.5% Triton, 10 mM Tris-
HCl, pH 7.6, 120 mM NaCl, 25 mM KCl, 1.8 mM CaCl, 1 mM sodium
vanadate, 50 mM NaF, and a mixture of protease inhibitors (Sigma-
Aldrich) on a rocker platform for 30 min at 4
 
 
 
C. In the GST pull-down ex-
periments, cells were grown on 10-cm diam culture plates for 3 d, washed
in PBS, and extracted in the same buffer containing 1% NP-40 instead of
Triton X-100. Solubilized material was recovered by pelleting at 18.000 
 
g
 
for 15 min at 4
 
 
 
C. Supernatants were collected and protein concentration
determined using the protein assay kit (Bio-Rad Laboratories). For immuno-
precipitation, cells expressing GFP-Rab13Q67L were grown for 3 d on 10-
cm diam culture plates, washed with PBS, and extracted in IP buffer (50
mM NaCl, 25 mM Tris, pH 8, 1 mM EDTA, 0.25% Triton, 1 mM sodium
vanadate, 50 mM NaF, and protease inhibitors). After centrifugation, su-
pernantants were incubated with 5 
 
 
 
g of anti-VASP antibody over night at
4
 
 
 
C. Protein G agarose beads were added for 2 h and the beads washed
three times with IP buffer. Equal amount of protein were separated by SDS-
PAGE and transferred electrophoretically to nitrocellulose filters. Filters
were probed with anti-VASP or anti–P-VASP antibodies before ECL detec-
tion according to the manufacturer’s protocols (Pierce Chemical Co.).
 
GST pull-down assay
 
GST-Rab13 fusion protein was expressed in 
 
E. coli
 
 and purified accord-
ing to the manufacturer’s protocol (Amersham Biosciences). GST-Rab13
bound to glutathione beads was loaded with 1 mM GDP or GTP
 
 
 
S (a
poorly hydrolyzable GTP analogue) for 90 min at RT in incubation buffer
(100 mM NaCl, 20 mM Tris, 10 mM EDTA, 5 mM MgCl
 
2
 
, and 1 mM DTT,
pH 7.6). After washing, beads were incubated overnight with MDCK cell
extracts at 4
 
 
 
C. To prove the direct interaction of Rab13 with PKA, 100 
 
 
 
g
of purified PKA catalytic subunit from bovine heart (Sigma-Aldrich) was in-
cubated with a 10-fold molar excess of purified GST, GST-Rab13-GDP, or
GST-Rab13-GTP
 
 
 
S proteins in the incubation buffer overnight at 4
 
 
 
C.
GST-Rab6 (a gift from B. Goud and S. Monier, UMR144 Institut Curie) was
used as negative control. After washing, the extent of PKA binding was de-
termined by SDS-PAGE and Western blotting using polyclonal anti-PKA 
 
 
 
cat or anti-PKC
 
 
 
 antibodies.
 
In vitro kinase assay
 
10 U of purified PKA catalytic subunit was incubated with VASP immuno-
precipitate and either 1 
 
 
 
g of protein kinase inhibitor peptide, PKI (Sigma-
Aldrich), and 10 
 
 
 
g of purified GST-Rab13 loaded with GTP
 
 
 
S or GST in
kinase buffer (100 mM NaCl, 20 mM Tris, pH 7.5, 10 mM MgCl
 
2
 
, 1 mM
DTT, 1 mM ATP) for 30 min at 30
 
 
 
C. The reaction was stopped by adding
3
 
  
 
SDS sample buffer, separated on SDS-PAGE, and VASP phosphoryla-
tion determined by Western blot using the anti-VASP antibody.
 
Online supplemental material
 
The online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200312118/DC1. Fig. S1 shows that Rab13 mutants do
neither alter the recruitment of adherens junction proteins such as (A)
 
 
 
-catenin or (B) afadin nor (C) cortical actin in a calcium switch experi-
ment. Anti–
 
 
 
-catenin and anti-afadin antibodies were purchased from
Sigma-Aldrich and BD Transduction Laboratories, respectively. Phalloidin
was purchased from Sigma-Aldrich. Supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.jcb200312118/DC1.
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